{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:39:55Z","timestamp":1757543995629},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1038\/ncpendmet0047","type":"journal-article","created":{"date-parts":[[2006,5,16]],"date-time":"2006-05-16T17:00:15Z","timestamp":1147798815000},"page":"111-115","source":"Crossref","is-referenced-by-count":5,"title":["Diagnosis of adenomatous primary aldosteronism in a patient with severe hypertension"],"prefix":"10.1038","volume":"1","author":[{"given":"E Marie","family":"Freel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John MC","family":"Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpendmet0047_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P et al. (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89: 1045\u20131050","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0047_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P et al. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45: 1243\u20131248","journal-title":"J Am Coll Cardiol"},{"key":"BFncpendmet0047_CR3","first-page":"1863","volume":"85","author":"CE Fardella","year":"2000","unstructured":"Fardella CE et al. (2000) Primary aldosteronism in essential hypertensives: prevalence, biochemical profile and molecular biology. J Clin Endocrinol Metab 85: 1863\u20131867","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0047_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","volume":"31","author":"VM Montori","year":"2002","unstructured":"Montori VM and Young WF Jr (2002) Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism: a systematic review of the literature. Endocrinol Metab Clin North Am 31: 619\u2013632","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BFncpendmet0047_CR5","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","volume":"40","author":"P Mulatero","year":"2002","unstructured":"Mulatero P et al. (2002) Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension 40: 897\u2013902","journal-title":"Hypertension"},{"key":"BFncpendmet0047_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","volume":"217","author":"M Stowasser","year":"2004","unstructured":"Stowasser M and Gordon RD (2004) Primary aldosteronism\u2014careful investigation is essential and rewarding. Mol Cell Endocrinol 217: 33\u201339","journal-title":"Mol Cell Endocrinol"},{"key":"BFncpendmet0047_CR7","first-page":"460","volume":"16","author":"RT Kloos","year":"1995","unstructured":"Kloos RT et al. (1995) Incidentally discovered adrenal masses. Endocr Rev 16: 460\u2013484","journal-title":"Endocr Rev"},{"key":"BFncpendmet0047_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/00001622-200301000-00013","volume":"15","author":"GB Thompson","year":"2003","unstructured":"Thompson GB and Young WF Jr (2003) Adrenal incidentaloma. Curr Opin Oncol 15: 84\u201390","journal-title":"Curr Opin Oncol"},{"key":"BFncpendmet0047_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","volume":"135","author":"AM Sawka","year":"2001","unstructured":"Sawka AM et al. (2001) Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 135: 258\u2013261","journal-title":"Ann Intern Med"},{"key":"BFncpendmet0047_CR10","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1046\/j.1365-2125.1999.00070.x","volume":"48","author":"PO Lim","year":"1999","unstructured":"Lim PO et al. (1999) Raised ARR predicts antihypertensive efficacy of spironolactone\u2014a prospective cohort follow-up study. Br J Clin Pharmacol 48: 756\u2013760","journal-title":"Br J Clin Pharmacol"},{"key":"BFncpendmet0047_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7861\/clinmedicine.5-1-55","volume":"5","author":"S Hood","year":"2005","unstructured":"Hood S et al. (2005) Prevalence of primary aldosteronism measured by aldosterone\/renin ratio and spironolactone testing. Clin Med 5: 55\u201360","journal-title":"Clin Med"},{"key":"BFncpendmet0047_CR12","first-page":"650","volume":"240","author":"M De Gasparo","year":"1987","unstructured":"De Gasparo M et al. (1987) Three new epoxy-spironolactone derivatives; characterization in vivo and in vitro. J Pharmacol Exp Ther 240: 650\u2013656","journal-title":"J Pharmacol Exp Ther"},{"key":"BFncpendmet0047_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","volume":"15","author":"MH Weinberger","year":"2002","unstructured":"Weinberger MH et al. (2002) Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. Am J Hypertens 15: 709\u2013716","journal-title":"Am J Hypertens"},{"key":"BFncpendmet0047_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/01.HYP.0000025146.19104.FE","volume":"40","author":"H Krum","year":"2002","unstructured":"Krum H et al. (2002) Efficacy of eplerenone added to renin\u2013angiotensin blockade in hypertensive patients. Hypertension 40: 117\u2013123","journal-title":"Hypertension"},{"key":"BFncpendmet0047_CR15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.7326\/0003-4819-121-11-199412010-00010","volume":"121","author":"JD Blumenfeld","year":"1994","unstructured":"Blumenfeld JD et al. (1994) Diagnosis and treatment of primary aldosteronism. Ann Intern Med 121: 877\u2013885","journal-title":"Ann Intern Med"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0047","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:47:40Z","timestamp":1684439260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["BFncpendmet0047"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet0047","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}